These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37068915)

  • 1. Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases.
    Hasseli R; Richter JG; Hoyer BF; Lorenz HM; Pfeil A; Regierer AC; Schmeiser T; Strangfeld A; Voll RE; Krause A; Reckert S; Gräßler A; Saar P; Kapelle A; Backhaus M; Blank N; Henes J; Osiek S; Knothe A; Hoese G; Brandt-Jürgens J; Maltzahn A; Specker C; Müller-Ladner U; Schulze-Koops H; ;
    RMD Open; 2023 Apr; 9(2):. PubMed ID: 37068915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.
    Liew J; Gianfrancesco M; Harrison C; Izadi Z; Rush S; Lawson-Tovey S; Jacobsohn L; Ja C; Hyrich KL; Gossec L; Strangfeld A; Carmona L; Schäfer M; Frãzao-Mateus E; Bulina I; Stafford F; Tufan A; Graver C; Yardımcı GK; Zepa J; Al Emadi S; Cook C; Abutiban F; Dey D; Katigbak G; Kaufman L; Kowalski E; Martínez-Martínez MU; Patel NJ; Reyes-Cordero G; Salido E; Smith E; Snow D; Sparks J; Wise L; Bhana S; Gore-Massy M; Grainger R; Hausmann J; Sirotich E; Sufka P; Wallace Z; Machado PM; Robinson PC; Yazdany J
    RMD Open; 2022 Apr; 8(1):. PubMed ID: 35387864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    Bakasis AD; Mavragani CP; Voulgari PV; Gerolymatou N; Argyropoulou OD; Vlachoyiannopoulos PG; Skopouli FN; Tzioufas AG; Moutsopoulos HM
    J Autoimmun; 2022 Jul; 131():102846. PubMed ID: 35717727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy.
    Lombardi A; Villa S; Colaneri M; Scaglione G; Bai F; Varisco B; Bono V; Vena A; Dentone C; Russo C; Tettamanti M; Renisi G; Viero G; Azzarà C; Mantero M; Peyvandi F; Bassetti M; Marchetti G; Muscatello A; Nobili A; Gori A; Bandera A;
    J Infect Public Health; 2024 Mar; 17(3):467-473. PubMed ID: 38262085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases.
    Papagoras C; Fragoulis GE; Zioga N; Simopoulou T; Deftereou K; Kalavri E; Zampeli E; Gerolymatou N; Kataxaki E; Melissaropoulos K; Panopoulos S; Fragiadaki K; Evangelatos G; Bournia VK; Arida A; Karamanakos A; Pappa M; Panagiotopoulos A; Koutsianas C; Mparouta G; Dimitroulas T; Liossis SN; Tektonidou MG; Kravvariti E; Kougkas N; Georgiou P; Voulgari P; Elezoglou A; Bogdanos DP; Vassilopoulos D; Sfikakis PP
    Ann Rheum Dis; 2022 Jul; 81(7):1013-1016. PubMed ID: 34758975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
    Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
    Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases.
    Glintborg B; Jensen DV; Terslev L; Hendricks O; Østergaard M; Rasmussen SH; Jensen MP; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Sørensen CM; Krogh NS; Agerbo JN; Ziegler C; Hetland ML
    J Rheumatol; 2022 Oct; 49(10):1163-1172. PubMed ID: 35705237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel.
    Maltezou HC; Gamaletsou MN; Giannouchos TV; Koukou DM; Karapanou A; Sourri F; Syrimi N; Lemonakis N; Peskelidou E; Papanastasiou K; Souliotis K; Lourida A; Panagopoulos P; Hatzigeorgiou D; Sipsas NV
    J Hosp Infect; 2023 Feb; 132():46-51. PubMed ID: 36473554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough SARS-CoV-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: A National COVID Cohort Collaborative study.
    Ge J; Digitale JC; Pletcher MJ; Lai JC;
    Hepatology; 2023 Mar; 77(3):834-850. PubMed ID: 36799617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases.
    Patel NJ; Cook C; Vanni K; Fu X; Wang X; Kawano Y; Qian G; Hang B; Srivatsan S; Banasiak EP; Kowalski E; Bade K; Zhang Y; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2023 Apr; 82(4):565-573. PubMed ID: 36442978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study.
    Wu JT; La J; Branch-Elliman W; Huhmann LB; Han SS; Parmigiani G; Tuck DP; Brophy MT; Do NV; Lin AY; Munshi NC; Fillmore NR
    JAMA Oncol; 2022 Feb; 8(2):281-286. PubMed ID: 34854921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
    Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
    Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
    Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X
    Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.
    Palazzo L; Lindblom J; Kihlgren Olsson E; Nikiphorou E; Wincup C; Saha S; Shaharir SS; Katchamart W; Akarawatcharangura Goo P; Traboco L; Chen YM; Lilleker JB; Nune A; Pauling JD; Agarwal V; Dzifa D; Toro Gutiérrez CE; Caballero-Uribe CV; Chinoy H; ; Agarwal V; Gupta L; Parodis I
    Rheumatol Int; 2024 Oct; 44(10):1923-1933. PubMed ID: 39138675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes.
    Bea S; Choi A; Kim JH; Cho YM; Choi WS; Jung J; Shin JY
    Diabetes Obes Metab; 2023 Sep; 25(9):2734-2742. PubMed ID: 37312652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
    Boekel L; Stalman EW; Wieske L; Hooijberg F; van Dam KPJ; Besten YR; Kummer LYL; Steenhuis M; van Kempen ZLE; Killestein J; Volkers AG; Tas SW; van der Kooi AJ; Raaphorst J; Löwenberg M; Takkenberg RB; D'Haens GRAM; Spuls PI; Bekkenk MW; Musters AH; Post NF; Bosma AL; Hilhorst ML; Vegting Y; Bemelman FJ; Voskuyl AE; Broens B; Parra Sanchez A; van Els CACM; de Wit J; Rutgers A; de Leeuw K; Horváth B; Verschuuren JJGM; Ruiter AM; van Ouwerkerk L; van der Woude D; Allaart CF; Teng YKO; van Paassen P; Busch MH; Jallah PBP; Brusse E; van Doorn PA; Baars AE; Hijnen DJ; Schreurs CRG; van der Pol WL; Goedee HS; Vogelzang EH; Leeuw M; Atiqi S; van Vollenhoven R; Gerritsen M; van der Horst-Bruinsma IE; Lems WF; Nurmohamed MT; Boers M; Keijzer S; Keijser J; van de Sandt C; Boogaard A; Cristianawati O; Ten Brinke A; Verstegen NJM; Zwinderman KAH; van Ham SM; Rispens T; Kuijpers TW; Wolbink G; Eftimov F;
    Lancet Rheumatol; 2022 Jun; 4(6):e417-e429. PubMed ID: 35527808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.